Pathogenetic Mechanisms of Deep Infiltrating Endometriosis

Reproductive Sciences

Volumn 22, Issue 9, 2015, Pages 1053-1059

  Tosti, Claudia ^a,b   Pinzauti, Serena ^a,b   Santulli, Pietro ^b,c   Chapron, Charles ^b,c   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Institut Cochin   (France)

^c INSTITUT COCHIN   (France)

Author keywords

apoptosis; deep infiltrating endometriosis; endometrioma; inflammation; neuroangiogenesis; oxidative stress; pathogenesis; pelvic pain; peritoneal endometriosis

Indexed keywords

ACTIVIN; CELL ADHESION MOLECULE; CYTOKINE; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; NERVE GROWTH FACTOR; PROGESTERONE RECEPTOR; REACTIVE OXYGEN METABOLITE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; VASCULOTROPIN; PROSTAGLANDIN;

AGGRESSION; ANGIOGENESIS; APOPTOSIS; B CELL LYMPHOMA; CELL ADHESION; CELL PROLIFERATION; DEEP INFILTRATING ENDOMETRIOSIS; ENDOMETRIOSIS; GYNECOLOGIC DISEASE; HUMAN; INFLAMMATION; LYMPHOCYTE; NATURAL KILLER CELL; OXIDATIVE STRESS; PATHOGENESIS; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYMPTOMATOLOGY; URETER; VAGINA; ANIMAL; ENDOMETRIUM; FEMALE; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYTOKINES; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; IRON; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PHENOTYPE; PROGNOSIS; PROSTAGLANDINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 84939175013     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719115592713     Document Type: Review

References (67)

1. Sampson J,. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927; 14: 422-469.
2. Machado DE, Abrão MS, Berardo PT, Takiya CM, Nasciutti LE,. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril. 2008; 90 (1): 148-155.
3. Abrão MS, Podgaec S, Dias JA Jr,. Deeply infiltrating endometriosis affecting the rectum and lymph nodes. Fertil Steril. 2006; 86 (3): 543-547.
4. Noel JC, Chapron C, Fayt I, Anaf V,. Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril. 2008; 89 (5): 1069-1072.
5. Sasson IE, Taylor HS,. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci. 2008; 1127: 106-115.
6. Gargett CE, Schwab KE, Brosens J, Puttemans P, Benagiano G, Brosens I,. Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis. Mol Hum Reprod. 2014; 20 (7) 591-598.
7. Bulun SE,. Endometriosis. N Engl J Med. 2009; 360 (3): 268-279.
8. Young VJ, Brown KJ, Saunders PT, Horne AW,. The role of the peritoneum in the pathogenesis of endometriosis. Human Reprod Update. 2013; 19 (5): 558-569.
9. Chapron C, Chopin N, Borghese B,. Deeply infiltrating endometriosis: pathogenetic implications of the anatomical distribution. Hum Reprod. 2006; 21 (7) 1839-1845.
10. Sanchez AM, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M,. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014; 20 (2): 217-230.
11. Luisi S, Renner SP, Santulli P,. Endometrioma: from pathogenesis to clinical management. J Endometriosis. 2013; 5 (3): 91-99.
12. Nisolle M, Donnez J,. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril. 1997; 68 (4): 585-596.
13. Abrão MS, Neme RM, Carvalho FM, Aldrighi JM, Pinotti JA,. Histological classification of endometriosis as a predictor of response to treatment. Int J Gynecol Obstet. 2003; 82 (1): 31-40.
14. Kamergorodsky G, Ayroza Ribeiro PA, Longo Galvao MA,. Histologic classification of specimens from women affected by superficial endometriosis, deeply infiltrating endometriosis, and ovarian endometriomas. Fertil Steril. 2009; 92 (6): 2074-2077.
15. Anaf V, Simon P, Fayt I, Noel J,. Smooth muscles are frequent components of endometriotic lesions. Hum Reprod. 2000; 15 (4): 767-771.
16. Noël JC, Chapron C, Bucella D,. Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis. Fertil Steril. 2010; 93 (6): 1774-1777.
17. Anaf V, Nakadi I, Simon E,. Preferential infiltration of large bowel endometriosis along the nerves of the colon. Hum Reprod. 2004; 19 (4): 996-1002.
18. Chapron C, Fauconnier A, Vieira M,. Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Hum Reprod. 2003; 18 (1): 157-161.
19. Bulun SE, Monsavais D, Pavone ME,. Role of estrogen receptor-beta in endometriosis. Semin Reprod Med. 2012; 30 (1): 39-45.
20. Bukulmez O, Hardy DB, Carr BR, Word RA, Mendelson CR,. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology. 2008; 149 (3): 1190-1204.
21. Dassen H, Punyadeera C, Kamps R, Word RA, Mendelson CR,. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod. 2007; 22: 3148-3158.
22. Han SJ, O'Malley BW,. The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis. Hum Reprod Update. 2014; 20 (4): 467-484.
23. Bulun SE, Cheng YH, Pavone ME,. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med. 2010; 28 (1): 36-43.
24. Bulun SE, Cheng YH, Yin P,. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006; 248 (1-2): 94-103.
25. Reis FM, Petraglia F, Taylor RN,. Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update. 2013; 19 (4): 406-418.
26. Zanatta A, Pereira RM, Rocha AM,. The relationship among HOXA10, estrogen receptor α progesterone receptor, and progesterone receptor b proteins in rectosigmoid endometriosis: a tissue microarray study. Reprod Sci. 2015; 22 (1): 31-37.
27. Santulli P, Marcellin L, Noel JC,. Sphingosine pathway deregulation in endometriotic tissues. Fertil Steril. 2012; 97 (4): 904-911.
28. Lambert S, Santulli P, Chouzenoux S,. Endometriosis: increasing concentrations of serum interleukin-1β and interleukin-1sRII is associated with the deep form of this pathology. J Gynecol Obstet Biol Reprod (Paris). 2014; 43 (9): 735-743.
29. Santulli P, Borghese B, Chouzenoux S,. Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Fertil Steril. 2013; 99 (1): 219-226.
30. Carmona F, Chapron C, Martínez-Zamora MA,. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol. 2012; 95 (1-2): 80-86.
31. Santulli P, Borghese B, Noel JC,. Hormonal therapy deregulates prostaglandin-endoperoxidase synthetase 2 (PTGS2) expression in endometriotic tissues. J Clin Endocrinol Metab. 2014; 99 (3): 881-890.
32. Banu SK, Lee J, Speights VO Jr,. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkB and b-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol Endocrinol. 2009; 23 (2): 1291-1205.
33. Chapron C, Souza C, Borghese B,. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod. 2011; 26 (8): 2028-2035.
34. Braga de Paula L, Pereira Braga N, Mendonça M,. Apoptosis of ectopic endometrial cells is impaired in women with endometriosis. J Endometriosis. 2012; 4: 17-20.
35. Wieser F, Vigne JL, Ryan I, Hornung D, Djalali S, Taylor RN,. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab. 2005; 90 (12): 6441-6447.
36. Defrère S, Lousse JC, Gonza lez-Ramos R, Colette S, Donnez J, Van Langendonckt A,. Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Mol Hum Reprod. 2008; 14 (7): 377-385.
37. Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D,. Oxidative stress and endometriosis. Hum Reprod. 2005; 20 (7): 2014-2020.
38. Ngô C, Chereau C, Nicco C, Weill B, Chapron C, Batteux F,. Reactive oxygen species controls endometriosis progression. Am J Pathol. 2009; 175 (1): 225-234.
39. Ngô C, Nicco C, Leconte M,. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. J Pathol. 2010; 222 (2): 148-157.
40. Leconte M, Nicco C, Ngô C,. The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. Am J Pathol. 2011; 179 (2): 880-889.
41. Santulli P, Chouzenoux S, Fiorese M,. Protein oxidative stress markers in peritoneal fluid of women with deep infiltrating endometriosis are increased. Hum Reprod. 2015; 30 (1): 49-60.
42. Ferreira MC, Witz CA, Hammes LS, Kirma N, Petraglia F, Schenken RS, Reis FM,. Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum. Mol Hum Reprod. 2008; 14 (5): 301-307.
43. Liu YG, Tekmal RR, Binkley PA, Nair HB, Schenken RS, Kirma NB,. Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta. Mol Hum Reprod. 2009; 15 (10): 665-673.
44. Carrarelli P, Rocha AL, Belmonte G,. Increased expression of antimüllerian hormone and its receptor in endometriosis. Fertil Steril. 2014; 101 (5): 1353-1358.
45. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG,. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab. 2002; 87 (10): 4782-4791.
46. Borghese B, Chiche JD, Vernerey D,. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression. Hum Reprod. 2008; 23 (5): 1207-1213.
47. Wu MH, Shoji Y, Wu MC,. Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol. 2005; 167 (4): 1061-1069.
48. Leconte M, Chouzenoux S, Nicco C,. Role of the CXCL12-CXCR4 axis in the development of deep rectal endometriosis. J Reprod Immunol. 2014; 103: 45-52.
49. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L,. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril. 2002; 78 (1): 148-153.
50. Gonzalez-Ramos R, Donnez J, Defrère S,. Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod. 2007; 13 (7): 503-509.
51. Brawn J, Morotti M, Zondervan KT, Becker CM, Vincent K,. Central changes associated with chronic pelvic pain and endometriosis. Hum Reprod Update. 2014; 20 (5): 737-747.
52. Morotti M, Vincent K, Brawn J, Zondervan KT, Becker CM,. Peripheral changes in endometriosis-associated pain. Hum Reprod Update. 2014; 20 (5): 717-736.
53. Asante A, Taylor RN,. Endometriosis: the role of neuroangiogenesis. Annu Rev Physiol. 2011; 73: 163-182.
54. Tokushige N, Markham R, Russell P, Fraser IS,. Nerve fibres in peritoneal endometriosis. Hum Reprod. 2006; 21 (11): 3001-3007.
55. Tulandi T, Felemban A, Chen MF,. Nerve fibers and histopathology of endometriosis-harboring peritoneum. J Am Assoc Gynecol Laparosc. 2001; 8 (1): 95-98.
56. Zhang X, Yao H, Huang X, Lu B, Xu H, Zhou C,. Nerve fibres in ovarian endometriotic lesions in women with ovarian endometriosis. Hum Reprod. 2010; 25 (2): 392-397.
57. Wang G, Tokushige N, Markham R, Fraser IS,. Rich innervation of deep infiltrating endometriosis. Hum Reprod. 2009; 24 (4): 827-834.
58. Wang G, Tokushige N, Russell P, Dubinovsky S, Markham R, Fraser IS,. Hyperinnervation in intestinal deep infiltrating endometriosis. J Minim Invas Gyn. 2009; 16 (6): 713-719.
59. Anaf V, El Nakadi I, De Moor V, Chapron C, Pistofidis G, Noel JC,. Increased nerve density in deep infiltrating endometriotic nodules. Gynecol Obstet Inves. 2011; 71 (2): 112-117.
60. Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noël JC,. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril. 2006; 86 (5): 1336-1343.
61. McKinnon B, Bersinger NA, Wotzkow C, Mueller MD,. Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations. Fertil Steril. 2012; 97 (2): 373-380.
62. Vercellini P, Viganò P, Somigliana E, Fedele L,. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014; 10 (5): 261-275.
63. Colette S, Defrère S, Van Kerk O, Van Langendonckt A, Dolmans MM, Donnez J,. Differential expression of steroidogenic enzymes according to endometriosis type. Fertil Steril. 2013; 100 (6): 1642-1649.
64. Santulli P, Chouzenoux S, Fiorese M,. Protein oxidative stress markers in peritoneal fluids of women with deep infiltrating endometriosis are increased. Hum Reprod. 2015; 30 (1): 49-60.
65. McKinnon BD, Bertschi D, Bersinger NA, Mueller MD,. Inflammation and nerve fiber interaction in endometriotic pain. Trends Endocrinol Metab. 2015; 26 (1): 1-10.
66. Streuli I, de Ziegler D, Santulli P,. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 2013; 14 (3): 291-305.
67. Abrão MS, Petraglia F, Falcone T, Keckstein J, Osuga Y, Chapron C,. Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management. Hum Reprod Update. 2015; 21 (3): 329-339.